tirzepatide kidney linked to lower risk for death, adverse CV and outcomes vs. GLP-1s Tirzepatide, HFpEF, and the Kidney:

[Google Scholar] 26.Weghuber D, Barrett T, Barrientos-Prez M, Gies I, Hesse D, Jeppesen OK, Kelly AS, Mastrandrea LD, Srrig R, Arslanian S STEP TEENS Investigators

For rate analysis of G protein BRET assays, data were fitted to a one-phase association curve

A review of patents and innovative biopolymer-based hydrogels

Because three receptor systems are involved, reducing the dose to manage side effects may disproportionately affect one pathway more than others, leading to unpredictable changes in the benefit profile

In March, Novo Nordisk introduced NovoCare Pharmacy, a direct-to-patient delivery service to improve access to Wegovy for cash-paying patients

Basic Clin Neurosci (2016) 7(2):13742